Long-term use of antibiotics and risk of colorectal adenoma

Authors

Yin Cao, Massachusetts General Hospital and Harvard Medical School & Harvard T.H. Chan School of Public Health
Kana Wu, Harvard T.H. Chan School of Public Health
Raaj Mehta, Massachusetts General Hospital and Harvard Medical School
David A. Drew, Massachusetts General Hospital and Harvard Medical School
Mingyang Song, Massachusetts General Hospital and Harvard Medical School & Harvard T.H. Chan School of Public Health
Paul Lochhead, Massachusetts General Hospital and Harvard Medical School
Long H. Nguyen, Massachusetts General Hospital and Harvard Medical School
Jacques Izard, University of Nebraska–LincolnFollow
Charles S. Fuchs, Yale Cancer Center & Yale School of Medicine & Smilow Cancer Hospital
Wendy S. Garrett, Dana-Farber Cancer Institute and Harvard Medical School & Broad Institute of MIT and Harvard & Harvard T.H. Chan School of Public Health
Curtis Huttenhower, Broad Institute of MIT and Harvard & Harvard T.H. Chan School of Public Health
Shuji Ogino, Dana-Farber Cancer Institute and Harvard Medical School & Harvard T. H. Chan School of Public Health & Brigham and Women’s Hospital and Harvard Medical School
Edward L. Giovannucci, Harvard T.H. Chan School of Public Health & Brigham and Women’s Hospital and Harvard Medical School & Harvard T. H. Chan School of Public Health
Andrew T. Chan, Massachusetts General Hospital and Harvard Medical School & Brigham and Women’s Hospital and Harvard Medical School & Broad Institute of MIT and Harvard,Follow

Date of this Version

4-1-2019

Citation

Gut. 2018 April ; 67(4): 672–678. doi:10.1136/gutjnl-2016-313413.

Abstract

Objective—Recent evidence suggests that antibiotic use, which alters the gut microbiome, is associated with an increased risk of colorectal cancer. However, the association between antibiotic use and risk of colorectal adenoma, the precursor for the majority of colorectal cancers, has not been investigated.

Design—We prospectively evaluated the association between antibiotic use at age 20–39 and 40–59 (assessed in 2004) and recent antibiotic use (assessed in 2008) with risk of subsequent colorectal adenoma among 16,642 women aged ≥60 enrolled in the Nurses’ Health Study who underwent at least one colonoscopy through 2010. We used multivariate logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs).

Results—We documented 1,195 cases of adenoma. Increasing duration of antibiotic use at age 20–39 (Ptrend=0.002) and 40–59 (Ptrend=0.001) was significantly associated with an increased risk of colorectal adenoma. Compared to non-users, women who used antibiotics for ≥2 months between age 20–39 had a multivariable OR of 1.36 (95% CI: 1.03–1.79). Women who used ≥2 months of antibiotics between age 40–59 had a multivariable OR of 1.69 (95% CI: 1.24–2.31). The associations were similar for low-risk vs. high-risk adenomas (size ≥1 cm, or with tubulovillous/villous histology, or ≥3 detected lesions), but appeared modestly stronger for proximal compared with distal adenomas. In contrast, recent antibiotic use within the past 4 years was not associated with risk of adenoma (Ptrend=0.44).

Conclusions—Long-term antibiotic use in early to middle adulthood was associated with increased risk of colorectal adenoma.